Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-02-04

Clinical Trial Update: Characterization of the Incretinpathy in Type 2 Diabetes Initiated After Sixty Years Old

View source ↗

Summary

A completed clinical trial from the University of Campinas characterizes incretinopathy in individuals with Type 2 diabetes diagnosed after age 60, focusing on …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Campinas, Brazil | Conditions: Diabetes Mellitus, Type 2, Insulin Resistance | Status: COMPLETED